miércoles, 24 de julio de 2024

Long-acting injectable cabotegravir for HIV prevention is safe in pregnancy NIH-sponsored study supports cabotegravir use throughout period of reproductive potential.

https://www.nih.gov/news-events/news-releases/long-acting-injectable-cabotegravir-hiv-prevention-safe-pregnancy

No hay comentarios:

Publicar un comentario